Citation 89162

MIMAKI,Y: YOKOSUKA,A: SAKUMA,C: SAKAGAMI,H: SASHIDA,Y:. (2002). SPIROSTANOL PENTAGLYCOSIDES FROM THE UNDERGROUND PARTS OF POLIANTHES TUBEROSA.. 65(10)

Citation Details

Title	SPIROSTANOL PENTAGLYCOSIDES FROM THE UNDERGROUND PARTS OF POLIANTHES TUBEROSA.
Authors	MIMAKI,Y: YOKOSUKA,A: SAKUMA,C: SAKAGAMI,H: SASHIDA,Y:
Year	2002
Volume	65
Issue	10

Summary

Year: 2002

Journal: Unknown

Organisms and Their Experiments (1)

Polianthes tuberosa (AGAVACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SPIROSTAN-12-ONE,5-ALPHA: 2-BETA-[(O-ALPHA-L-ARABINOPYRANOSYL(1-3)-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]: 25(R):	None
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-12-ONE,5-ALPHA: 2-BETA-[(O-ALPHA-L-ARABINOPYRANOSYL(1-3)-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]: 25(R):	WEAK ACTIVITY
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-12-ONE,5-ALPHA: 2-BETA-[(O-ALPHA-L-ARABINOPYRANOSYL(1-3)-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]: 25(R):	WEAK ACTIVITY
5	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SPIROSTAN-12-ONE,5-ALPHA: 3-BETA-[(O-ALPHA-L-ARABINOPYRANOSYL(1-3)-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]: 25(R):	None
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-12-ONE,5-ALPHA: 3-BETA-[(O-ALPHA-L-ARABINOPYRANOSYL(1-3)-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]: 25(R):	ACTIVE
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-12-ONE,5-ALPHA: 3-BETA-[(O-ALPHA-L-ARABINOPYRANOSYL(1-3)-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]: 25(R):	ACTIVE
8	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SPIROSTAN-12-ONE,5-ALPHA: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-3)-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]: 25(R):	None
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-12-ONE,5-ALPHA: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-3)-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]: 25(R):	WEAK ACTIVITY
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-12-ONE,5-ALPHA: 3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-3)-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]: 25(R):	ACTIVE
11	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SPIROSTAN-12-ONE,5-ALPHA: 3-BETA-[(O-BETA-D-XYLOPYRANOSYL(1-3)-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]: 25(R):	None
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-12-ONE,5-ALPHA: 3-BETA-[(O-BETA-D-XYLOPYRANOSYL(1-3)-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]: 25(R):	ACTIVE
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-12-ONE,5-ALPHA: 3-BETA-[(O-BETA-D-XYLOPYRANOSYL(1-3)-BETA-D-GLUCOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSYL)-OXY]: 25(R):	WEAK ACTIVITY

Show SPARQL Queries (1)